JPH04164021A - Composition for oral cavity - Google Patents
Composition for oral cavityInfo
- Publication number
- JPH04164021A JPH04164021A JP2289447A JP28944790A JPH04164021A JP H04164021 A JPH04164021 A JP H04164021A JP 2289447 A JP2289447 A JP 2289447A JP 28944790 A JP28944790 A JP 28944790A JP H04164021 A JPH04164021 A JP H04164021A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- oil
- glycyrrhiza
- composition
- menthol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 210000000214 mouth Anatomy 0.000 title abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 28
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 241000196324 Embryophyta Species 0.000 claims abstract description 6
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims abstract description 3
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 claims abstract 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims abstract 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 13
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 13
- 229940010454 licorice Drugs 0.000 claims description 13
- DRDRYGIIYOPBBZ-XBXARRHUSA-N Licochalcone B Chemical compound COC1=C(O)C(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1 DRDRYGIIYOPBBZ-XBXARRHUSA-N 0.000 claims description 4
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 claims description 3
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 claims description 2
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 claims description 2
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical group COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical group C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 claims 1
- 229940093767 glabridin Drugs 0.000 claims 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 claims 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims 1
- 241000202807 Glycyrrhiza Species 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 10
- 208000002925 dental caries Diseases 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 4
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000010266 Aggressive Periodontitis Diseases 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 241001278898 Glycyrrhiza inflata Species 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000000551 dentifrice Substances 0.000 abstract 1
- 201000006727 periodontosis Diseases 0.000 abstract 1
- 229940069445 licorice extract Drugs 0.000 description 25
- 230000000844 anti-bacterial effect Effects 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 15
- 229940041616 menthol Drugs 0.000 description 12
- 239000005973 Carvone Substances 0.000 description 10
- 239000002324 mouth wash Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 229940051866 mouthwash Drugs 0.000 description 5
- 208000028169 periodontal disease Diseases 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000606125 Bacteroides Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000186044 Actinomyces viscosus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 235000012539 Bacterium linens Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、う蝕や歯周病の病原菌を抑制し、う蝕や歯周
病の予防および治療に有用な歯磨、マウスウォッシュ、
パスタなどの口腔組成物に関する。Detailed Description of the Invention [Field of Industrial Application] The present invention provides toothpastes, mouthwashes,
It relates to oral compositions such as pasta.
[従来の技術および課題]
う蝕や歯周病はある種の口腔内細菌による感染症であり
、う蝕の原因菌としてはストレプトフッカス・ミュータ
ンスがその代表的なものであり、歯周病の原因菌として
はバクテロイデス・ジンジバリスに代表されるダラム陰
性の嫌気性菌がその候補に挙げられている。このような
観点から、う蝕や歯周病を予防あるいは治療する手段の
一つとして、抗菌剤により病原菌を抑える試みがなされ
ており、従来、クロルヘキシジンや塩化セチルピリジニ
ウムなどの合成抗菌剤が歯磨やマウスウォッシュに配合
され、その効果が確認されている。[Conventional techniques and issues] Caries and periodontal disease are infections caused by certain oral bacteria, and Streptofuccus mutans is a typical bacterial cause of caries. Durham-negative anaerobic bacteria, represented by Bacteroides gingivalis, are candidates for the causative bacteria of the disease. From this perspective, attempts have been made to suppress pathogenic bacteria using antibacterial agents as a means of preventing or treating caries and periodontal disease. Conventionally, synthetic antibacterial agents such as chlorhexidine and cetylpyridinium chloride have been used in tooth brushing It has been added to mouthwash and its effectiveness has been confirmed.
しかし、これらの長期間の使用や、口中への適用を考え
た場合、安全性の面から天然由来の抗菌剤を使う方が好
ましいと考えられる。ところが、これまで、口腔内の病
原菌に対する天然由来の抗菌剤の検討は十分にはなされ
ていない。However, when considering long-term use of these agents and application to the mouth, it is considered preferable to use naturally derived antibacterial agents from the standpoint of safety. However, to date, natural antibacterial agents against pathogenic bacteria in the oral cavity have not been sufficiently investigated.
近年、甘草抽出物に関する研究がすすむにつれて、各種
フラボノイドを含有する油溶性画分に、酸化防止作用(
特開昭58−217583号)、酵素阻害作用(特開平
1−149706号)、抗菌作用(特開昭59〜462
10号)なとの有用な作用か見い出されており、抗菌作
用にっし)での検討かなされている。しかし、抗菌作用
にっL)では、これまで検討された菌種の範囲では、グ
ラム陰性菌に対しての抗菌作用は低く(フラグランス・
ジャーナル、6,122−125.1989)、口腔細
菌に対する効果はほとんど検討されていない。特に、グ
ラム陰性菌である歯周病原性菌に対する効果は全く不明
である。In recent years, as research on licorice extract has progressed, the oil-soluble fraction containing various flavonoids has been shown to have antioxidant effects (
JP-A No. 58-217583), enzyme inhibitory action (JP-A No. 1-149706), antibacterial action (JP-A No. 59-462)
No. 10) has been found to have a useful effect, and its antibacterial effect is also being investigated. However, its antibacterial activity against Gram-negative bacteria is low within the range of bacterial species studied so far (Fragrans, L).
Journal, 6, 122-125.1989), but the effect on oral bacteria has hardly been investigated. In particular, the effect on periodontal pathogenic bacteria, which are Gram-negative bacteria, is completely unknown.
[課題を解決するための手段]。[Means for solving problems].
本発明者らは、これらの事情に鑑み、甘草の油溶性画分
の歯周病の予防・治療への応用を種々検討した。その結
果、甘草の油溶性エキス(以下、油溶性甘草エキスとい
う)が意外にもダラム陰性嫌気性菌である歯周病原性菌
のバクテロイデス・ジンツバリスに非常に強い抗菌活性
を示すこと、および油溶性甘草エキスに少量のターメン
トールおよび/またはρ−カルボンを添加することによ
り、その抗菌活性か著しく高まり、バクテロイデス・ジ
ンツバリスだけでなく、う蝕の原因菌であるストレプト
コッカス・ミコータンスや歯肉炎の原因菌であるアクチ
ノマイセス・ヒスコーザスにも強い抗菌活性を示すこと
を見い出し、本発明を完成するに至った。In view of these circumstances, the present inventors have conducted various studies on the application of the oil-soluble fraction of licorice to the prevention and treatment of periodontal disease. As a result, the oil-soluble extract of licorice (hereinafter referred to as oil-soluble licorice extract) unexpectedly showed very strong antibacterial activity against the periodontal pathogen Bacteroides gintsuvaris, which is a Durum-negative anaerobic bacterium. By adding a small amount of termenthol and/or ρ-carvone to licorice extract, its antibacterial activity is significantly increased, and it is effective against not only Bacteroides gintsuvaris but also Streptococcus mycotans, which is a bacterium that causes caries, and the bacteria that causes gingivitis. It was discovered that a certain Actinomyces hiscosus also exhibits strong antibacterial activity, leading to the completion of the present invention.
すなわち、本発明は、油溶性甘草エキスを配合してなる
ことを特徴とする口腔用組成物、好ましくは、該油溶性
甘草エキスとQ−メントールおよび/またはρ−カルボ
ンを配合してなる口腔用組成物を提供するものである。That is, the present invention provides an oral composition comprising an oil-soluble licorice extract, preferably an oral composition comprising an oil-soluble licorice extract and Q-menthol and/or ρ-carvone. A composition is provided.
本発明の口腔用組成物は、う蝕や歯周病の原因菌を著し
く抑制し、これら疾患の予防や治療に非常に有用である
。The oral composition of the present invention significantly suppresses bacteria causing caries and periodontal disease, and is extremely useful for preventing and treating these diseases.
本発明の口腔用組成物における抗菌成分として用いる油
溶性甘草エキスは、甘草またはその同属植物、例えば、
グリチリザ・グラグラ(Glycyrrhiza g
labra Linne) 、グリチリザeインフラ
タ (G 1ycyrrhiza 1nflata
Batalin)、グリチリザ・アラレアシス(G
Iycyrrhizaaraleasis)なとから得
られる油溶性のエキスで、特に、根から抽出されるもの
か好ましい。これらの油溶性甘草エキスには有効成分と
して、クラブリジン、グラブレン、リコプ1)レへン。The oil-soluble licorice extract used as the antibacterial component in the oral composition of the present invention may be prepared from licorice or its congeners, for example,
Glycyrrhiza g
G lycyrrhiza 1nflata
Batalin), Glychiriza araresis (G.
It is an oil-soluble extract obtained from Iycyrrhiza araleasis, and in particular, one extracted from the root is preferable. These oil-soluble licorice extracts include clavulizine, glabrene, and lycope as active ingredients.
八、リコブJ7レコンB、リコクマロノか含有されてい
ることが判明しており、本発明においては、該油溶性甘
草エキスとして、これら有効成分の1種または2種以上
を高含量、例えば、エキス乾燥重量に基づいて0.5重
量%以上含量するものを用いることか好ましい。また、
該油溶性甘草エキスとして、これら有効成分の単離物な
いしは濃縮物の1種または2種以上を用いてもよい。8. It has been found that the oil-soluble licorice extract contains Ricobu J7 Recon B and Ricokumarono. In the present invention, the oil-soluble licorice extract contains one or more of these active ingredients in a high content, for example, by drying the extract. It is preferable to use one containing 0.5% by weight or more based on weight. Also,
As the oil-soluble licorice extract, one or more of these active ingredient isolates or concentrates may be used.
該油溶性甘草エキスは、通常、甘草またはその間属植物
、好ましくは、その根を有機溶媒、例えば、メタノール
、エタノール、アセトン、酢酸エチル、クロロホルムな
どで抽出することにより得られる。抽出原料は生、乾燥
植物体いずれでもよく、また、植物体を水で抽出処理し
て甘味料等として有用なグリチルリチン等を抽出した残
渣であってもよい。抽出操作は通常の有機溶媒による抽
出に公知の方法を採用することかできる。The oil-soluble licorice extract is usually obtained by extracting licorice or its related plants, preferably its roots, with an organic solvent such as methanol, ethanol, acetone, ethyl acetate, chloroform, etc. The raw material for extraction may be either fresh or dried plant matter, or it may be a residue obtained by extracting glycyrrhizin, which is useful as a sweetener, etc., by extracting the plant body with water. For the extraction operation, methods known for extraction using ordinary organic solvents can be employed.
本発明においては、該油溶性甘草エキスを口腔用組成物
全量に対してエキス乾燥重量として、00005〜10
重量%、好ましくは、0005〜5重量%配合すること
により、所望の効果か得られる。In the present invention, the oil-soluble licorice extract is expressed as an extract dry weight of 00005 to 10
The desired effect can be obtained by blending the components in an amount of 0.005 to 5% by weight.
また、本発明においては、前記のごとく、C−メントー
ルおよび/またはQ−カルボンを配合することが好まし
く、これにより、油溶性甘草エキスの抗菌活性が上昇す
る。ターメントールおよびa−カルボンは、各々、口腔
用組成物全量に対して、0005〜5重量%配合するこ
とにより、所望の抗菌活性上昇効果が発揮される。余り
に多量の配合は口腔用組成物の香味に影響するので好ま
しくない。Furthermore, in the present invention, as described above, it is preferable to incorporate C-menthol and/or Q-carvone, which increases the antibacterial activity of the oil-soluble licorice extract. By blending termenthol and a-carvone in an amount of 0005 to 5% by weight based on the total amount of the oral composition, the desired effect of increasing antibacterial activity is exhibited. Incorporation of too large a quantity is not preferable because it affects the flavor of the oral composition.
本発明の口腔用組成物は常法にしたがって、歯磨、マウ
スウォッシュ、パスタ、チューインガム、キャンデー等
の形態とすることができ、他の配合成分は特に限定する
ものではなく、通常、この種の組成物に配合されるもの
が使用できる。The oral composition of the present invention can be made into the form of toothpaste, mouthwash, pasta, chewing gum, candy, etc. according to a conventional method, and the other ingredients are not particularly limited. You can use the one that is mixed into the product.
[実施例]
つぎに、実施例および試験例を挙げて、本発明をさらに
詳しく説明する。[Example] Next, the present invention will be explained in more detail by giving Examples and Test Examples.
実施例1
甘草(G 1ycyrrhiza glabra
L 1nne)および甘草(G 1ycyrrhiza
1nflata Batalin)の根1kfl
に無水エタノール1012を加え、還流下で5時間抽出
を行った。得られた抽出液を減圧濃縮し、乾燥後残渣に
酢酸エチル10ρを加え5時間抽出を行った。酢酸エチ
ル抽出液を減圧濃縮、乾燥してそれぞれ約30gのエキ
スAおよびBを得た。Example 1 Licorice (G lycyrrhiza glabra)
L 1nne) and licorice (G 1ycyrrhiza
1kfl root of 1nflata Batalin)
Anhydrous ethanol 1012 was added to the solution, and extraction was performed under reflux for 5 hours. The obtained extract was concentrated under reduced pressure, and after drying, 10 ρ of ethyl acetate was added to the residue and extracted for 5 hours. The ethyl acetate extract was concentrated under reduced pressure and dried to obtain about 30 g of extracts A and B, respectively.
それぞれエキスAおよびエキスBの代表的フラボノイド
の含有率をHPLCで定量した結果、以下の通りであっ
た。The content of typical flavonoids in Extract A and Extract B was determined by HPLC, and the results were as follows.
エキスAニゲラブリジン約10%、グラブレン約3%
エキスB:リコカルコンA約20%、リコカルコンB約
1.5%
実施例2
甘草(G Iycyrrhiza araleasi
s)の根2kyに、ヘキサン:エタノール−2:lの混
合溶媒l0I2を加え、還流下2時間抽出を行った。抽
出液を減圧濃縮後乾燥し、約409のエキスCを得た。Extract A Nigellabridin approx. 10%, Glabrene approx. 3% Extract B: Licochalcone A approx. 20%, Licochalcone B approx. 1.5% Example 2 Licorice (G Iycyrrhiza araleasi)
A mixed solvent of hexane:ethanol-2:l (10I2) was added to 2ky roots of s), and extraction was performed under reflux for 2 hours. The extract was concentrated under reduced pressure and dried to obtain about 409 Extract C.
エキスCは代表的フラボノイドとしてリコクマロン約2
%を含有していた。Extract C contains approximately 2 licocumaron as a representative flavonoid.
It contained %.
実施例3
油溶性甘草エキスAとQ−カルボンを配合した練歯磨を
つぎの処方で作成した。Example 3 A toothpaste containing oil-soluble licorice extract A and Q-carvone was prepared according to the following formulation.
水酸化アルミニウム 45%カラギーナン
0.5アルギン酸ナトリウム
0.5ゼラチン
0.3プロピレングリコール 3.0ソ
ルビツト液 30ラウリル硫酸ナ
トリウム 1.2ラウリン酸ジエタノールア
ミド 1.5サツカリンナトリウム
0.1油溶性甘草エキスA O,IQ
−カルボン 0.5精製水
残合計 100.0
%
実施例4
油溶性甘草エキスCとQ−メントールを配合したマウス
ウォッシュをっぎの処方で作成した。Aluminum hydroxide 45% carrageenan 0.5 sodium alginate
0.5 gelatin
0.3 Propylene glycol 3.0 Sorbiturate liquid 30 Sodium lauryl sulfate 1.2 Lauric acid diethanolamide 1.5 Sodium saccharin
0.1 oil-soluble licorice extract A O, IQ
-Carvone 0.5 purified water
Total remaining 100.0
% Example 4 A mouthwash containing oil-soluble licorice extract C and Q-menthol was prepared according to the following recipe.
エチルアルコール 15.0%ソルビット
1O10クエン酸
0.05クエン酸ナトリ、ラム
02安息香酸ナトリウム 0,2
ラウリル硫酸ナトリウム 0.2サツカリンナ
トリウム 0.05青色1号
0.001油溶性甘草エキスC002
g−メントール 0.05精製氷
残
合計 t o o、o%
実施例5
つぎに示す組成で常法に従いチューインガムを調製した
。Ethyl alcohol 15.0% sorbitol 1O10 citric acid
0.05 Sodium citrate, rum
02 Sodium benzoate 0,2
Sodium lauryl sulfate 0.2 Saccharin sodium 0.05 Blue No. 1
0.001 Oil-soluble licorice extract C002 g-menthol 0.05 Purified ice
Total remaining t o o, o% Example 5 Chewing gum was prepared according to a conventional method with the composition shown below.
チューインガムベース 20%粉糖
51.15
ブドウ糖 10水飴
18
油溶性甘草エキスB O,05ρ−メン
トール 0,8合計 10
0.0%
実施例6
つぎに示す組成で常法に従いハードキャンデーを調製し
た。Chewing gum base 20% powdered sugar
51.15 Glucose 10 Starch syrup
18 Oil-soluble licorice extract B O,05ρ-menthol 0,8 total 10
0.0% Example 6 Hard candy was prepared according to a conventional method using the composition shown below.
グラニユー糖 46.8%水飴
52.34
クエン酸 0.3油溶性甘草
エキスA O,03〃CO,03
g−カルボン 0.5合計
100.0%
試験例!
実施例1および2で抽出した油溶性甘草エキスA、B、
C,Q−メントールおよびQ−カルボンの3種の口腔内
細菌に対する最小発育阻止濃度(MIC)をプレイン・
ハート・インフユーノヨンブロス(BHrブロス)を用
いる液体培地希釈法により求めた。なお、陽性対照とし
て抗菌剤である塩化セチルピリジニウムを用いた。約1
08個/紅に調製した細菌@濁液と、種々濃度に調製し
た各被験薬剤をBHIブロス中で混合し、37℃、48
時間嫌気培養(HtlO%、C0,5%、N、85%)
後、細菌の発育の有無を肉眼で判定した。発育が認めら
れない最小濃度をMIC(μ9/ml)とした。結果を
表1に示す。Granulated sugar 46.8% starch syrup
52.34 Citric acid 0.3 Oil-soluble licorice extract A O,03〃CO,03 g-Carvone 0.5 Total
100.0% Test example! Oil-soluble licorice extracts A and B extracted in Examples 1 and 2,
The minimum inhibitory concentration (MIC) of C, Q-menthol and Q-carvone against three types of oral bacteria was determined in plain form.
It was determined by a liquid medium dilution method using Heart Infection Broth (BHr Broth). Note that cetylpyridinium chloride, an antibacterial agent, was used as a positive control. Approximately 1
08 bacteria/suspension of red bacteria and each test drug prepared at various concentrations were mixed in BHI broth, and incubated at 37°C and 48°C.
Time anaerobic culture (HtlO%, C0,5%, N, 85%)
Afterwards, the presence or absence of bacterial growth was visually determined. The minimum concentration at which no growth was observed was defined as MIC (μ9/ml). The results are shown in Table 1.
表1
381゛
最小発育阻止濃度、μ9/11ρ
油溶性甘草エキスA、B、Cはいずれも供試した菌株に
対して313〜100μ9/II(lの範囲て抗菌活性
を示した。特に、ダラム陰性の嫌気性菌であるバクテロ
イデス・ジンツバリスに対しては3.13〜6.25μ
9/酎のMICであり、優れた抗菌活性を示した。しか
し、その活性は塩化セチルピリジニウムに比べ低かった
。一方、Q−メントールおよびQ−カルボンには使用し
た濃度範囲では抗菌活性は認められなかった。Table 1 381゛Minimum inhibitory concentration, μ9/11ρ Oil-soluble licorice extracts A, B, and C all showed antibacterial activity in the range of 313 to 100 μ9/II (l) against the tested bacterial strains. 3.13-6.25μ for Bacteroides gintubalis, a negative anaerobic bacterium.
9/MIC of chu, indicating excellent antibacterial activity. However, its activity was lower than that of cetylpyridinium chloride. On the other hand, no antibacterial activity was observed for Q-menthol and Q-carvone within the concentration range used.
試験例2
Q−メントール、ρ−カルボンなど香料成分の存在下、
油溶性甘草エキスAおよびBの口腔内細菌に対する抗菌
活性を検討した。100μg/xQあるいは500μg
/x(lの香料成分を含むBHIブロスに種々の濃度の
甘草エキスを添加し、試験例1と同様に植菌・培養後、
生育の有無を判定した。結果を表2に示す。結果は各香
料成分の存在下抗菌活性を示す最小濃度の甘草エキス量
μ9/xQで示した。Test Example 2 In the presence of fragrance ingredients such as Q-menthol and ρ-carvone,
The antibacterial activity of oil-soluble licorice extracts A and B against oral bacteria was investigated. 100μg/xQ or 500μg
Licorice extract of various concentrations was added to BHI broth containing /
The presence or absence of growth was determined. The results are shown in Table 2. The results are expressed as the minimum concentration of licorice extract μ9/xQ that exhibits antibacterial activity in the presence of each fragrance component.
表2
無添加 50 50 3.13 6.25
ターメツトール
100μLi/xQ 12.5 12.5 0.7
8 1.56500μti/峠 6.25 6.25
0,39 0.39Q−カル本゛ン
100μ9/*Q 25 25 1.56 1
.56500μ9/xQ 12,5 12.5 0
,78 0.78アニスアテ゛ヒト
500μ9/峠 50 50 3.13 6.2
5シナミフクアルテ゛ヒト
500μ9/ytQ 50 50 3.13
6.25イソアミルアセテート
500μ9/岐 50 50 3.13 6.2
5バニリン
−」勧T暫−漫−−ヱー 3.13 6半−抗菌活性を
示す最小濃度二μ9/wρ
表2のごとくQ−メントールおよびC−カルボンの存在
により甘草エキスA、Bの抗菌活性は著しく増大した。Table 2 No additives 50 50 3.13 6.25
Termettol 100μLi/xQ 12.5 12.5 0.7
8 1.56500μti/pass 6.25 6.25
0,39 0.39Q-cal main 100μ9/*Q 25 25 1.56 1
.. 56500μ9/xQ 12.5 12.5 0
,78 0.78 Anis Athlete 500μ9/touge 50 50 3.13 6.2
5 Shinami Fukuarthito 500μ9/ytQ 50 50 3.13
6.25 Isoamyl acetate 500μ9/branch 50 50 3.13 6.2
5.Vanillin 3.13 6.13 Minimum concentration showing antibacterial activity 2μ9/wρ As shown in Table 2, the presence of Q-menthol and C-carvone makes licorice extracts A and B antibacterial. Activity increased significantly.
一方、その他の香料成分は甘草エキスの抗菌活性には影
響を与えなかった。On the other hand, other fragrance ingredients did not affect the antibacterial activity of licorice extract.
試験例3
実施例4の処方に従い、油溶性甘草エキスCとQ−メン
トール配合のマウスウオツンユ(被験界)を作成した。Test Example 3 According to the formulation of Example 4, a mouse water tsunyu (tested world) containing oil-soluble licorice extract C and Q-menthol was prepared.
一方、Q−メントールの代わりに同濃度のバニリン配合
のマウスウオツンユ(対照界1)および油溶性甘草エキ
スC無配合のマウスウォッシュ(対照界2)を作成し、
抗菌活性を比較した。On the other hand, a mouthwash containing the same concentration of vanillin instead of Q-menthol (Control World 1) and a mouthwash containing no oil-soluble licorice extract C (Control World 2) were created.
The antibacterial activity was compared.
BHI寒天培地を加熱滅菌後50℃に冷却し、これにあ
らかじめBHIブロスで培養したアクチノマイセス・ビ
スコ−サスTl4V菌液を約10’個IRQ)となるよ
う添加し、ただちに直径90+no+の滅菌シャーレに
10xQずつ分注し、固化した。この平板上に内径8
ff1m、高さ10nmの円筒を立て、中に前記3種の
マウスウォッシュを満たし、37℃、48時間嫌気培養
後、細菌の生育していないゾーン(阻止内)の直径を測
定し抗菌活性を判定し結果を表3に示す。After heat sterilizing the BHI agar medium, cool it to 50°C, add a solution of Actinomyces viscosus Tl4V bacteria cultured in BHI broth in advance to about 10' cells (IRQ), and immediately transfer to a sterile Petri dish with a diameter of 90+no+. The solution was dispensed into 10xQ portions and solidified. On this flat plate, the inner diameter is 8
Erect a cylinder with a f/1 m and a height of 10 nm, fill it with the three types of mouthwashes mentioned above, and after culturing anaerobically at 37°C for 48 hours, measure the diameter of the zone where no bacteria grow (inside the inhibition) to determine antibacterial activity. The results are shown in Table 3.
表3
被験品 対照界l 対照界2
阻止用の直径 15 8 0
(mm)
表3のごとく、油溶性甘草エキスCを含まない対照界2
には全く阻止用が認められなかった。一方、対照界1で
は円筒の内径部分のみに阻止用がみられたのに対し、甘
草エキスCとQ−メントールの両者を配合した被験品で
は大きい阻止用が形成され、強い抗菌活性を示した。Table 3 Test product Control field 1 Control field 2 Diameter for inhibition 15 8 0 (mm) As shown in Table 3, control field 2 not containing oil-soluble licorice extract C
No inhibitory effect was observed at all. On the other hand, in Control Area 1, inhibition was observed only in the inner diameter portion of the cylinder, whereas in the test product containing both licorice extract C and Q-menthol, a large inhibition was formed, indicating strong antibacterial activity. .
[発明の効果コ
本発明によれば、天然由来の抗菌剤を配合した、う蝕あ
るいは歯周病の予防あるいは治療にすぐれた効果を発揮
する口腔用組成物が得られる。[Effects of the Invention] According to the present invention, an oral composition containing a naturally-derived antibacterial agent and exhibiting excellent effects in preventing or treating dental caries or periodontal disease can be obtained.
Claims (5)
てなることを特徴とする口腔用組成物。(1) An oral composition characterized by containing an oil-soluble extract of licorice or its congenerous plants.
ルボンを配合した請求項(1)記載の口腔用組成物。(2) The oral composition according to claim (1), which contains the oil-soluble extract and l-menthol or l-carvone.
である請求項(1)または(2)記載の口腔用組成物。(3) The oral composition according to claim (1) or (2), wherein the oil-soluble extract is glabridin or glabren.
コンBである請求項(1)または(2)記載の口腔用組
成物。(4) The oral composition according to claim 1 or 2, wherein the oil-soluble extract is licochalcone A or licochalcone B.
)または(2)記載の口腔用組成物。(5) Claim (1) wherein the oil-soluble extract is licocumaron.
) or the oral composition described in (2).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2289447A JP2848688B2 (en) | 1990-10-26 | 1990-10-26 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2289447A JP2848688B2 (en) | 1990-10-26 | 1990-10-26 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04164021A true JPH04164021A (en) | 1992-06-09 |
| JP2848688B2 JP2848688B2 (en) | 1999-01-20 |
Family
ID=17743385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2289447A Expired - Lifetime JP2848688B2 (en) | 1990-10-26 | 1990-10-26 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2848688B2 (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07309733A (en) * | 1994-05-19 | 1995-11-28 | Kanebo Ltd | Composition for oral cavity |
| WO2003084556A1 (en) * | 2002-04-04 | 2003-10-16 | Kaneka Corporation | Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| KR20030093886A (en) * | 2002-06-05 | 2003-12-11 | 김영진 | Natural Herb Toothpaste |
| KR100413114B1 (en) * | 2001-03-30 | 2003-12-31 | 재단법인서울대학교산학협력재단 | Chitosan coated biodegradable polymeric materials for tissue regeneration and their fabrication methods |
| KR100414548B1 (en) * | 2000-08-28 | 2004-01-07 | 황재관 | Antibacterial composition for oral microorganisms using medicinal plant extracts and the extracting method thereof |
| KR100495030B1 (en) * | 1997-12-23 | 2006-02-01 | 주식회사 엘지생활건강 | Oral hygiene composition containing the encapsulated herbal extract |
| JP2009137860A (en) * | 2007-12-05 | 2009-06-25 | Seiren Co Ltd | Oral cavity care composition |
| JP2010526067A (en) * | 2007-05-02 | 2010-07-29 | トムズ・オブ・メイン・インコーポレーテッド | Antibacterial and anti-inflammatory isolates from licorice extract |
| US8877266B2 (en) | 2007-05-02 | 2014-11-04 | Tom's Of Maine, Inc. | Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from |
| CN110545787A (en) * | 2017-04-19 | 2019-12-06 | Wm.雷格利Jr.公司 | Synergistic effect of licorice extract and menthol in confectionery products for breath freshening |
| JP2022163809A (en) * | 2021-04-15 | 2022-10-27 | ライオン株式会社 | Improver of oral bacterial flora |
-
1990
- 1990-10-26 JP JP2289447A patent/JP2848688B2/en not_active Expired - Lifetime
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07309733A (en) * | 1994-05-19 | 1995-11-28 | Kanebo Ltd | Composition for oral cavity |
| KR100495030B1 (en) * | 1997-12-23 | 2006-02-01 | 주식회사 엘지생활건강 | Oral hygiene composition containing the encapsulated herbal extract |
| KR100414548B1 (en) * | 2000-08-28 | 2004-01-07 | 황재관 | Antibacterial composition for oral microorganisms using medicinal plant extracts and the extracting method thereof |
| KR100413114B1 (en) * | 2001-03-30 | 2003-12-31 | 재단법인서울대학교산학협력재단 | Chitosan coated biodegradable polymeric materials for tissue regeneration and their fabrication methods |
| US7166311B2 (en) | 2002-04-04 | 2007-01-23 | Kaneka Corporation | Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| WO2003084556A1 (en) * | 2002-04-04 | 2003-10-16 | Kaneka Corporation | Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| KR20030093886A (en) * | 2002-06-05 | 2003-12-11 | 김영진 | Natural Herb Toothpaste |
| JP2010526067A (en) * | 2007-05-02 | 2010-07-29 | トムズ・オブ・メイン・インコーポレーテッド | Antibacterial and anti-inflammatory isolates from licorice extract |
| US8877266B2 (en) | 2007-05-02 | 2014-11-04 | Tom's Of Maine, Inc. | Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from |
| EP2150233A4 (en) * | 2007-05-02 | 2015-08-12 | Tom S Of Maine Inc | Liquorice extract antimicrobial and anti-inflammatory isolates |
| JP2009137860A (en) * | 2007-12-05 | 2009-06-25 | Seiren Co Ltd | Oral cavity care composition |
| CN110545787A (en) * | 2017-04-19 | 2019-12-06 | Wm.雷格利Jr.公司 | Synergistic effect of licorice extract and menthol in confectionery products for breath freshening |
| JP2022163809A (en) * | 2021-04-15 | 2022-10-27 | ライオン株式会社 | Improver of oral bacterial flora |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2848688B2 (en) | 1999-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4112730B2 (en) | Antibacterial agent for oral cavity | |
| CA2257596A1 (en) | Antimicrobial agents for oral hygiene products | |
| JPH04164021A (en) | Composition for oral cavity | |
| KR102408893B1 (en) | Composition for prevention or treatment of oral disease comprising Pueraria Extract | |
| JPH09110687A (en) | Anti-caries and anti-periodontal composition | |
| JP3009531B2 (en) | Periodontal disease prevention agent | |
| KR101881636B1 (en) | Composition for prevention or treatment of oral disease comprising Pueraria Extract | |
| KR100492034B1 (en) | Antibacterial agent and oral composition for preventing and treating caries and periodontal disease containing panduratin derivatives | |
| KR20170103476A (en) | Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract | |
| JP2012067065A (en) | Anti-periodontic disease medicine | |
| KR102415612B1 (en) | Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract | |
| CN114668803B (en) | A method for preparing collutory for preventing dental caries and periodontitis | |
| KR102810951B1 (en) | Oral composition containing Polygalae Radix extracts | |
| JPH0640867A (en) | Composition for oral cavity application | |
| KR102820423B1 (en) | Oral composition containing Nux-Vomica extracts | |
| KR20100003411A (en) | Oral care compositions containing alismae rhizoma extract for preventing tooth decay | |
| KR20170103482A (en) | Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract | |
| KR102540804B1 (en) | Composition containing Torreya nucifera extracts for preventing the formation of biofilm of mmicroorgaism | |
| KR20170120399A (en) | Composition for prevention or treatment of oral disease comprising Genistein | |
| KR101818211B1 (en) | Composition for prevention or treatment of oral disease comprising Arctill fructus Extract | |
| KR20170120411A (en) | Composition for prevention or treatment of oral disease comprising Scopoletin | |
| CN120478467A (en) | Oral care composition with antibacterial and senile dementia preventing effects | |
| KR20170142975A (en) | Composition for prevention or treatment of oral disease comprising Leonurus sibiricus extract | |
| KR20190124074A (en) | Composition containing Berberis amurensis extracts for preventing the formation of biofilm of microorganism | |
| KR20170120408A (en) | Composition for prevention or treatment of oral disease comprising Qucercetin 3-glucoside |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081106 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091106 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091106 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101106 Year of fee payment: 12 |
|
| EXPY | Cancellation because of completion of term |